Chang Jyh-Lurn, Chen Gang, Lampe Johanna W, Ulrich Cornelia M
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
Environ Mol Mutagen. 2006 Aug;47(7):503-8. doi: 10.1002/em.20219.
Single-cell gel electrophoresis (the Comet assay) can be used to measure DNA damage and DNA repair capacity (DRC). However, to test DRC of cryopreserved lymphocytes, published methods include steps for cell culturing and phytohemagglutinin stimulation, which may limit use of this assay in intervention studies. We developed a modified Comet assay protocol that allows us to measure DRC from cryopreserved lymphocytes without these in vitro manipulations. Assay reproducibility was evaluated by performing the assay six times on different dates using six aliquots from one blood draw of one individual. The interindividual variation was assessed by performing the assay using one aliquot from six individuals. When gamma-irradiation was used as the mutagen, intra-assay coefficients of variation (CVs.) for baseline DNA damage, damage after gamma-irradiation exposure, and DRC--measured as tail moment--were 8, 31, and 10%, respectively. Interindividual CVs. were higher. When H(2)O(2) was used as the mutagen, intra-assay CVs. for damage measurements were lower for a protocol modification that included damage and repair at 37 degrees C (CVs. ranging from 8 to 35%) than for the more standard 4 degrees C protocol. Analyzing moment arm--the average distance of DNA migration within the tail--yielded similar results. DNA repair was successfully detected in each experiment. Comparing freshly isolated lymphocytes to cryopreserved lymphocytes from the same individuals' blood draw indicated that DRC was highly correlated when determined using moment arm values. This modified protocol extends the use of the Comet assay to measuring DRC in intervention studies (e.g., dietary interventions) in that it assesses cellular response after cryopreservation without cell culture or other extensive manipulation.
单细胞凝胶电泳(彗星试验)可用于测量DNA损伤和DNA修复能力(DRC)。然而,为了检测冷冻保存淋巴细胞的DRC,已发表的方法包括细胞培养和植物血凝素刺激步骤,这可能会限制该试验在干预研究中的应用。我们开发了一种改良的彗星试验方案,可让我们在不进行这些体外操作的情况下,测量冷冻保存淋巴细胞的DRC。通过使用来自同一个体一次采血的六个等分试样,在不同日期进行六次试验来评估试验的重现性。通过使用来自六个个体的一个等分试样进行试验来评估个体间差异。当使用γ射线照射作为诱变剂时,以尾矩测量的基线DNA损伤、γ射线照射暴露后的损伤和DRC的试验内变异系数(CVs)分别为8%、31%和10%。个体间CVs更高。当使用H₂O₂作为诱变剂时,对于包括在37℃进行损伤和修复的方案修改,损伤测量的试验内CVs(CVs范围为8%至35%)低于更标准的4℃方案。分析力矩臂(即尾巴内DNA迁移的平均距离)产生了类似的结果。在每个实验中都成功检测到了DNA修复。将新鲜分离的淋巴细胞与来自同一个体采血的冷冻保存淋巴细胞进行比较表明,使用力矩臂值测定时,DRC高度相关。这种改良方案将彗星试验的应用扩展到在干预研究(如饮食干预)中测量DRC,因为它在不进行细胞培养或其他广泛操作的情况下评估冷冻保存后的细胞反应。